NANOG and breast carcinoma: Expression of VIM, CDH1, CDH2, PLS3, CXCR4, CD44 and NANOG have been found in healthy controls and the maximal expression levels of these genes were the threshold beyond which CTCs-EBF of breast cancer patients were considered positive (Table S2, Figure S1).